AI-generated analysis. Always verify with the original filing.
Scinai Immunotherapeutics Ltd. received a Nasdaq notification on March 12, 2026, stating non-compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2), as the closing bid price of its ADSs was below $1.00 for 30 consecutive business days. The Company has 180 calendar days until September 8, 2026, to regain compliance, with no immediate effect on listing or trading.